Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy of AIDS.

A G Dalgleish1

  • 1Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London, UK.

Current Opinion in Biotechnology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Immunotherapy for Acquired Immunodeficiency Syndrome (AIDS) is being explored. Early trials suggest post-infection vaccines might delay disease progression in some individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Oncoimmunology·2018
Same author

The T4 molecule: function and structure.

Immunology today·2014
Same author

B cells in the pathogenesis of AIDS.

Immunology today·2014
Same author

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study.

The British journal of dermatology·2013
Same author

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis.

British journal of cancer·2012

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Acquired Immunodeficiency Syndrome (AIDS) immunotherapy is a complex field.
  • Previous attempts using stimulating and immunomodulating agents have shown limited success.
  • Recent advancements include passive immunotherapy and therapeutic vaccines.

Purpose of the Study:

  • To review the current landscape of AIDS immunotherapy.
  • To evaluate the potential of novel therapeutic strategies.

Main Methods:

  • Review of existing clinical and laboratory observations.
  • Analysis of preliminary clinical trial data.

Main Results:

  • Stimulating and immunomodulating agents have not yielded significant success.

Related Experiment Videos

  • Passive immunotherapy and therapeutic vaccine approaches are under investigation.
  • Preliminary data suggest post-infection vaccines may delay AIDS progression in some patients.

    • Conclusions:

    • Post-infection vaccines show promise in delaying AIDS progression.
    • Further research is warranted to optimize immunotherapy strategies for AIDS.